Cargando…
Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
Glucocerebrosidase (GBA1) mutations are the major genetic risk factor for Parkinson’s Disease (PD). The pathogenic mechanism is still unclear, but alterations in lysosomal-autophagy processes are implicated due to reduction of mutated glucocerebrosidase (GCase) in lysosomes. Wild-type GCase activity...
Autores principales: | Magalhaes, J., Gegg, M. E., Migdalska-Richards, A., Schapira, A. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780491/ https://www.ncbi.nlm.nih.gov/pubmed/29362387 http://dx.doi.org/10.1038/s41598-018-19479-8 |
Ejemplares similares
-
Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016) -
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014) -
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
por: Magalhaes, Joana, et al.
Publicado: (2016) -
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017) -
Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model
por: Yang, Shi Yu, et al.
Publicado: (2022)